REGENXBIO Inc. (NASDAQ:RGNX) Receives $31.88 Average Target Price from Analysts
REGENXBIO Inc. (NASDAQ:RGNX – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the six research firms that are presently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month price […]
REGENXBIO Inc. (NASDAQ:RGNX – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the six research firms that are presently covering the stock, Marketbeat reports. One equities research analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average twelve-month price […]
